A generic drug is identical to the branded drug. It is sold at a much lower price than the branded price. Generic version of a drug is sold after patents on the original medicine expire.
To promote the consumption of generics in the country, the committee has "recommended strongly that the government bring in legislation to make it legally binding on all doctors to prescribe only generic drugs in their prescriptions".
Noting that there is huge variation between the prices of branded and generic medicines, the panel said that medicines should be provided at cheaper rates to the common man on priority basis.
These suggestions come at a time when government is looking at ways to attract foreign funds in diverse sectors including pharmaceuticals.
In its report on 'FDI in Pharmaceutical Sector', the panel said it was concerned about the shift of ownership of generic drug makers to the hands of multinational firms, that results in change of business model and marketing strategy.
According to the committee, since 2006-07, seven domestic pharma companies were acquired by foreign players "at highly over-valued prices".
The panel does not have any reservation against 100 per cent FDI in green field projects under automatic route, he added.
India is a leading player in the generics drug market and exports around Rs 42,000 crore worth medicines annually.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
